Old Web
English
Sign In
Acemap
>
authorDetail
>
Guohua Pan
Guohua Pan
Janssen Pharmaceutica
Medicine
Stroke
Diabetes mellitus
Atrial fibrillation
Population
4
Papers
22
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Incidence rate of hospitalization and mortality in the first year following initial diagnosis of cardiac amyloidosis in the US claims databases.
2021
Current Medical Research and Opinion
Lu Wang
Joel N. Swerdel
James Weaver
Brendan M Weiss
Guohua Pan
Zhong Yuan
Peter M. DiBattiste
Show All
Source
Cite
Save
Citations (0)
Influence of age on the pharmacokinetics, pharmacodynamics, efficacy, and safety of rivaroxaban
2018
Current Medical Research and Opinion
Kenneth Todd Moore
Peggy Wong
Liping Zhang
Guohua Pan
JoAnne Foody
Show All
Source
Cite
Save
Citations (1)
Risk Prediction for Ischemic Stroke and Transient Ischemic Attack in Patients Without Atrial Fibrillation: A Retrospective Cohort Study
2017
Journal of Stroke & Cerebrovascular Diseases
Zhong Yuan
Erica A. Voss
Frank J. DeFalco
Guohua Pan
Patrick B. Ryan
Daniel Yannicelli
Christopher C. Nessel
Show All
Source
Cite
Save
Citations (4)
Rivaroxaban: a novel oral anticoagulant for the prevention and treatment of several thrombosis‐mediated conditions
2013
Annals of the New York Academy of Sciences
Troy Sarich
Gary Peters
Scott D. Berkowitz
Frank Misselwitz
Christopher C. Nessel
Paul Burton
Nancy Cook-Bruns
Anthonie W. A. Lensing
Lloyd Haskell
Elisabeth Perzborn
Dagmar Kubitza
Kenneth Todd Moore
Sanjay Jalota
Juergen Weber
Guohua Pan
Xiang Sun
Torsten Westermeier
A. Nadel
Leonard Oppenheimer
Peter M. DiBattiste
Show All
Source
Cite
Save
Citations (17)
1